Gagan Harsh Sharma
#962Managing Director
61
Age
16y
Exp
4y
Tenure
5/10
Risk
🎓 B.E. Electronics & Communication
🏛️ None
CompensationTBP
Personality
5
Open
5
Cons
5
Extr
5
Agre
5
Neur
Bliss GVS Pharma
Healthcare · Small Cap
Mature Stable · Founder-Centric
About
Gagan Harsh Sharma is the Managing Director of Bliss GVS Pharma, a Small Cap company in the Healthcare sector with a market cap of ₹2K Cr. A Pragmatic leader with 16 years of experience, he is known for intuition-driven decision-making and organic builder strategy. Leads through a focus on emerging market penetration and export-led growth consistent with mid-cap pharmaceutical sector norms.
FAQ
What is Gagan Harsh Sharma's leadership style?
Gagan Harsh Sharma is classified as a Pragmatic leader. He is intuition-driven in decision-making, with a legacy motivation and steady-marathon pace of execution.
What is Gagan Harsh Sharma's educational background?
Gagan Harsh Sharma holds a B.E. Electronics & Communication.
Who is the CEO of Bliss GVS Pharma?
Gagan Harsh Sharma is the Managing Director of Bliss GVS Pharma. He has been with the company for 4 years and in the current role for 4 years.
Leadership DNA
ArchetypePragmatic
MotivationLegacy
CrisisSteady Hand
DecisionIntuition-Driven
GrowthOrganic Builder
PeopleSystems-Builder
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployerSteady Employer
BrandValue-Champion
FocusMarket Expansion
OrientationDeep Specialist
Leadership Evidence
“Leads through a focus on emerging market penetration and export-led growth consistent with mid-cap pharmaceutical sector norms.”
⚡ Crisis●●●●○
Maintains consistent operational focus in the competitive generic pharmaceutical space without erratic shifts.
🎯 Motivation●●●●○
Focuses on long-term value preservation and steady growth of the family-led pharmaceutical enterprise.
👥 People●●●○○
Emphasizes structured manufacturing and compliance-driven processes inherent to the pharma sector.
📈 Growth●●●●○
Prioritizes steady portfolio expansion and market penetration over high-risk M&A activity.
💡 Innovation●●●●○
The company focuses on developing and marketing generic formulations and specialty products that leverage established therapeutic segments rather than pioneering new drug discovery.
🏃 Pace●●●●○
The company maintains a consistent, process-driven operational rhythm focused on steady growth in export markets and expanding its product portfolio in regulated and semi-regulated markets.
🌱 Purpose●●●○○
The company's strategic focus is primarily on market expansion and export growth, with CSR activities largely limited to statutory compliance requirements.
🏷️ Brand●●●●○
The company's market success is built on providing affordable, high-quality generic healthcare products, positioning it as a value-driven player in emerging economies.
🤝 Customer●●●●○
Bliss GVS operates primarily through a B2B model, supplying pharmaceutical formulations to distributors, hospitals, and government health departments across Africa and other emerging markets.
💼 Employer●●●○○
As a mature, promoter-led mid-to-small cap firm, it offers a predictable, stable work environment typical of established generic pharmaceutical manufacturers.
📋 Mandate
Strategic focus should shift to geographic penetration in emerging markets to leverage existing pharmaceutical capabilities.
🏢 Culture●●●○○
Strong promoter control and active management involvement define the strategic direction and daily operational focus.
Financials
Revenue FY25₹802 Cr
PAT FY25₹84 Cr
Rev CAGR 5Y2.8%
OPM12.2%
NPM10.5%
ROE8%
ROCE8.7%
P/E20
Fwd P/E—
P/B1.9
D/E4.5
Promoter62.4%
Institutional6.6%
Mkt Cap₹2K Cr
Compensation
To Be Published
Data being verified from audited reports
